Biotech Funding and Regulatory Shifts
Kilder
- Endpoints: Typewriter raises $56M for jumping gene technology and in vivo CAR-T therapies
- Labiotech: The biggest biotech funding rounds in August 2026
- Dealbreaker: Four Notable Health Tech Funding Announcements in August - Dealbreaker
- STAT: STAT+: ARPA-H funds biotechs working on custom RNA therapies
- Endpoints: China deaths reignite debate about using viruses to deliver CRISPR therapies
- GEN: Navigating the Regulatory Labyrinth: How Biotech Leaders Are Rethinking Strategy in an Uncertain Regulatory Era
- GEN: Regulatory Demands for More Process Control Data Fueling Innovation - genengnews.com
- GEN: Bicistornic Vectors + piggyBac = Improved Antibody Cell Line Production - genengnews.com
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.